北美肺科设备市场预测至 2027 年 - COVID-19 影响和按类型划分的区域分析(治疗设备、消耗品和配件、诊断设备和监测设备);应用(慢性阻塞性肺病(COPD)、睡眠呼吸暂停、哮喘、传染病等);和最终用户(医院、家庭护理机构和门诊护理中心)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 118    |    Report Code: TIPRE00013998    |    Category: Life Sciences

North America Pulmonary Devices Market

市场介绍

肺或呼吸装置主要用于患有呼吸系统疾病的患者慢性阻塞性肺病(COPD)、睡眠呼吸暂停、哮喘、传染病等疾病,以清除气道或呼吸道中的粘液和分泌物。这些医疗设备专注于与呼吸道相关问题的诊断、控制、治疗、管理和评估。

市场概况和动态< /span>

北美肺器械市场预计将从 2019 年的 75.8104 亿美元增至 2027 年的 166.3744 亿美元。 2019 年至 2027 年复合年增长率为 10.3%。 COVID-19病例数量的增加和呼吸系统疾病患病率的增加是预计推动北美肺部设备市场增长的主要因素。然而,市场可能会受到风险因素的影响,例如在预测期内与呼吸设备相关的不利报销情况。

主要细分市场

从类型来看,2019年治疗器械细分市场占据北美肺器械市场最大份额。从应用来看,慢性阻塞性肺疾病(COPD)细分市场在2019年北美肺器械市场中占据最大份额。就最终用户而言,医院细分市场在2019年北美肺器械市场中占据最大份额。

主要来源及上市公司

几大主要中小学与北美肺部设备市场报告相关的来源包括世界卫生组织 (WHO)、美国卫生与公众服务部、疾病控制与预防中心 (CDC) 等。

购买报告的理由

  • 它提供了对北美肺器械市场格局,并确定最有可能保证强劲回报的肺器械细分市场。
  • 它通过了解不断变化的趋势来指导保持领先地位。改变北美肺器械市场的竞争格局。
  • 它通过识别最有前景的细分市场,帮助有效规划肺器械市场的并购和合作伙伴交易销售
  • 它通过对北美肺器械市场各个细分市场的肺器械市场表现进行敏锐而全面的分析,促进明智的业务决策。
  • 提供了2019年至2027年期间基于各个细分市场的肺器械市场收入预测。

北美肺器械市场细分

按类型

  • 治疗设备
  • 耗材和配件
  • 诊断设备
  • 监控设备

 

按应用

  • 慢性阻塞性肺疾病 (COPD)
  • 睡眠呼吸暂停
  • 哮喘
  • 传染病
  • 其他

 

最终用户

  • 医院
  • 家庭护理环境
  • 流动护理中心

< strong> 

按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

 

公司简介

  • 瑞思迈
  • Masimo
  • Invacare Corporation
  • Koninklijke Philips NV
  • Getinge AB


North America Pulmonary Devices Strategic Insights

Strategic insights for North America Pulmonary Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-pulmonary-devices-market-strategic-framework.webp
Get more information on this report

North America Pulmonary Devices Report Scope

Report Attribute Details
Market size in 2019 US$ 7,581.04 Million
Market Size by 2027 US$ 16,637.44 Million
Global CAGR (2019 - 2027) 10.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 类型
  • 治疗设备
  • 耗材及配件
  • 诊断设备
  • 监测设备
By 应用
  • 慢性阻塞性肺病
  • 睡眠呼吸暂停
  • 哮喘
  • 传染病
By 最终用户
  • 医院
  • 家庭护理机构
  • 门诊护理中心
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • ResMed
  • Masimo
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Getinge AB
  • Get more information on this report

    North America Pulmonary Devices Regional Insights

    The regional scope of North America Pulmonary Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-pulmonary-devices-market-geography.webp
    Get more information on this report

    The List of Companies - North America Pulmonary Devices Market

    The List of Companies - North America Pulmonary Devices Market

    1. ResMed
    2. Masimo
    3. Invacare Corporation
    4. Koninklijke Philips N.V.
    5. Getinge AB

     

    Frequently Asked Questions
    How big is the North America Pulmonary Devices Market?

    The North America Pulmonary Devices Market is valued at US$ 7,581.04 Million in 2019, it is projected to reach US$ 16,637.44 Million by 2027.

    What is the CAGR for North America Pulmonary Devices Market by (2019 - 2027)?

    As per our report North America Pulmonary Devices Market, the market size is valued at US$ 7,581.04 Million in 2019, projecting it to reach US$ 16,637.44 Million by 2027. This translates to a CAGR of approximately 10.3% during the forecast period.

    What segments are covered in this report?

    The North America Pulmonary Devices Market report typically cover these key segments-

  • 类型 (治疗设备, 耗材及配件, 诊断设备, 监测设备)
  • 应用 (慢性阻塞性肺病, 睡眠呼吸暂停, 哮喘, 传染病)
  • 最终用户 (医院, 家庭护理机构, 门诊护理中心)
  • What is the historic period, base year, and forecast period taken for North America Pulmonary Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pulmonary Devices Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Pulmonary Devices Market?

    The North America Pulmonary Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ResMed
  • Masimo
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Getinge AB
  • Who should buy this report?

    The North America Pulmonary Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pulmonary Devices Market value chain can benefit from the information contained in a comprehensive market report.